Soebono H, Giphart M J, Schreuder G M, Klatser P R, de Vries R R
Department of Dermatology, Gadjah Mada University School of Medicine, Yogyakarta, Indonesia.
Int J Lepr Other Mycobact Dis. 1997 Jun;65(2):190-6.
To investigate whether the susceptibility to leprosy (type), subclinical infection with Mycobacterium leprae and the antibody response against M. leprae-specific antigens are associated with HLA-DR phenotypes sequence-specific oligonucleotide HLA-DRB1 and DQA1 typing and antibody assays have been performed in 79 leprosy patients (41 TT/BT and 38 LL/BL) and 50 healthy controls from a Javanese population in Yogyakarta, Indonesia. DRB102 was associated with LL/BL [odds ratio (OR) 2.54, 95% confidence interval (CI) 0.97-9.78, p = 0.037 and attributable risk (AR) 41.5%] but not with TT/BT leprosy (p > 0.05). HLA-DRB112 was negatively associated with leprosy (either LL/BL or TT/BT [OR 0.33-0.35, p < 0.05, prevented fraction (PF) 58.8%-65.3%]. No significant association was found between HLA-DRB1 or DQA1 type, anti-M. leprae antibody level and subclinical infection with M. leprae. These data indicate that in this population susceptibility to lepromatous leprosy is associated with HLA-DRB102, while resistance to leprosy is associated with HLA-DRB112. These associations are not paralleled with associations of the same HLA types with anti-M. leprae antibody level. Finally, the results of this study also support the notion that infection with M. leprae per se is not associated with HLA-DRB1 or DQA1 alleles.
为了研究麻风易感性(类型)、麻风分枝杆菌亚临床感染以及针对麻风分枝杆菌特异性抗原的抗体反应是否与HLA - DR表型相关,对印度尼西亚日惹爪哇人群中的79例麻风患者(41例TT/BT和38例LL/BL)和50名健康对照者进行了序列特异性寡核苷酸HLA - DRB1和DQA1分型及抗体检测。DRB102与LL/BL相关[比值比(OR)2.54,95%置信区间(CI)0.97 - 9.78,p = 0.037,归因风险(AR)41.5%],但与TT/BT型麻风无关(p > 0.05)。HLA - DRB112与麻风(LL/BL或TT/BT)呈负相关[OR 0.33 - 0.35,p < 0.05,预防分数(PF)58.8% - 65.3%]。未发现HLA - DRB1或DQA1类型、抗麻风分枝杆菌抗体水平与麻风分枝杆菌亚临床感染之间存在显著关联。这些数据表明,在该人群中,瘤型麻风易感性与HLA - DRB102相关,而对麻风的抵抗力与HLA - DRB112相关。这些关联与相同HLA类型与抗麻风分枝杆菌抗体水平的关联并不平行。最后,本研究结果也支持麻风分枝杆菌感染本身与HLA - DRB1或DQA1等位基因无关这一观点。